Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.
Apple's Latest Security Patch Fixes a Zero-Day Vulnerability Targeting
Chrome
-
Hackers have exploited the flaw against Chrome users already.
10 hours ago
Posts
quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?
ReplyDelete